Type I Collagen Abrogates the Clathrin-mediated Internalization of Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) via the MT1-MMP Hemopexin Domain*

Type I collagen (Col I)-stimulated matrix metalloproteinase-2 (MMP-2) activation via membrane type 1 MMP (MT1-MMP) involves both a transcriptional increase in MT1-MMP expression and a nontranscriptional response mediated by preexisting MT1-MMP. In order to identify which MT1-MMP domains were required for the nontranscriptional response, MCF-7 cells that lack endogenous MT1-MMP were transfected with either wild type or domain mutant MT1-MMP constructs. We observed that mutant constructs lacking the MT1-MMP cytoplasmic tail were able to activate MMP-2 in response to Col I but not a construct lacking the MT1-MMP hemopexin domain. Col I did not alter total MT1-MMP protein levels; nor did it appear to directly induce MT1-MMP oligomerization. Col I did, however, redistribute preexisting MT1-MMP to the cell periphery compared with unstimulated cells that displayed a more diffuse staining pattern. In addition, Col I blocked the internalization of MT1-MMP in a dynamin-dependent manner via clathrin-coated pit-mediated endocytosis. This mechanism of impaired internalization is different from that reported for concanavalin A, since it is not mediated by the cytoplasmic tail of MT1-MMP but rather by the hemopexin domain. In summary, upon Col I binding to its cell surface receptor, MT1-MMP internalization via clathrin-coated pit-mediated endocytosis is impaired through interactions with the hemopexin domain, thereby regulating its function and ability to activate MMP-2.

[1]  S. Apte,et al.  Egr-1 Mediates Extracellular Matrix-driven Transcription of Membrane Type 1 Matrix Metalloproteinase in Endothelium* , 1999, The Journal of Biological Chemistry.

[2]  P. Oh,et al.  Endothelial Caveolae Have the Molecular Transport Machinery for Vesicle Budding, Docking, and Fusion Including VAMP, NSF, SNAP, Annexins, and GTPases (*) , 1995, The Journal of Biological Chemistry.

[3]  J. Foidart,et al.  Coordinate enhancement of gelatinase a mRNA and activity levels in human fibroblasts in response to breast‐adenocarcinoma cells , 1994, International journal of cancer.

[4]  Carlos López-Otín,et al.  Strategies for MMP inhibition in cancer: innovations for the post-trial era , 2002, Nature Reviews Cancer.

[5]  M. Stack,et al.  Glycosylation Broadens the Substrate Profile of Membrane Type 1 Matrix Metalloproteinase* , 2004, Journal of Biological Chemistry.

[6]  María Yáñez-Mó,et al.  Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells. , 2003, Molecular biology of the cell.

[7]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[8]  D. Fishman,et al.  Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin. , 1999, Cancer research.

[9]  Ping Wang,et al.  The Hemopexin Domain of Membrane-type Matrix Metalloproteinase-1 (MT1-MMP) Is Not Required for Its Activation of proMMP2 on Cell Surface but Is Essential for MT1-MMP-mediated Invasion in Three-dimensional Type I Collagen* , 2004, Journal of Biological Chemistry.

[10]  Jan E. Schnitzer,et al.  Caveolae: mining little caves for new cancer targets , 2003, Nature Reviews Cancer.

[11]  M. Deckert,et al.  Endocytosis of GPI-anchored proteins in human lymphocytes: role of glycolipid-based domains, actin cytoskeleton, and protein kinases , 1996, The Journal of cell biology.

[12]  H. Sato,et al.  Complex Regulation of Membrane-type Matrix Metalloproteinase Expression and Matrix Metalloproteinase-2 Activation by Concanavalin a in Mda-mb-231 Human Breast Cancer Cells1 Activation of Which Has Been Associated with Metastatic Progression in Human Breast Cancer (hbc). Concanavalin a (con A) Has Be , 2022 .

[13]  M. McNiven,et al.  Participation of dynamin in the biogenesis of cytoplasmic vesicles , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  M. Seiki,et al.  Role of pericellular proteolysis by membrane-type 1 matrix metalloproteinase in cancer invasion and angiogenesis , 2003, Cancer and Metastasis Reviews.

[15]  A. Strongin,et al.  Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.

[16]  Hiroshi Ohno,et al.  Cytoplasmic tail–dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity , 2001, The Journal of cell biology.

[17]  W. T. Chen,et al.  Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. W. Rauser,et al.  Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Gillian Murphy,et al.  Membrane type I-matrix metalloproteinase (MT1-MMP) is internalised by two different pathways and is recycled to the cell surface , 2003, Journal of Cell Science.

[20]  L. Malerød,et al.  Clathrin-dependent endocytosis. , 2004, The Biochemical journal.

[21]  J. Keski‐Oja,et al.  Regulation of Membrane-type-1 Matrix Metalloproteinase Activity by Its Cytoplasmic Domain* , 2000, The Journal of Biological Chemistry.

[22]  M. Seiki,et al.  Intermolecular Autolytic Cleavage Can Contribute to the Activation of Progelatinase A by Cell Membranes (*) , 1995, The Journal of Biological Chemistry.

[23]  H. Birkedal‐Hansen,et al.  Gelatinase A (MMP-2) activation by skin fibroblasts: dependence on MT1-MMP expression and fibrillar collagen form. , 2001, Matrix biology : journal of the International Society for Matrix Biology.

[24]  Y. Okada,et al.  Cell surface binding and activation of gelatinase A induced by expression of membrane‐type‐1‐matrix metalloproteinase (MT1‐MMP) , 1996, FEBS letters.

[25]  Gillian Murphy,et al.  The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A , 1998, The Journal of Biological Chemistry.

[26]  K. Yoshioka,et al.  Membrane Type 1 Matrix Metalloproteinase Regulates Collagen-Dependent Mitogen-Activated Protein/Extracellular Signal-Related Kinase Activation and Cell Migration , 2004, Cancer Research.

[27]  M. Lippman,et al.  Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. , 1993, Journal of the National Cancer Institute.

[28]  S. Itohara,et al.  Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice , 2004, Oncogene.

[29]  F. Brodsky,et al.  Biological basket weaving: formation and function of clathrin-coated vesicles. , 2001, Annual review of cell and developmental biology.

[30]  H. Mori,et al.  Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration , 2001, The Journal of cell biology.

[31]  J. Guan,et al.  FAK-mediated src phosphorylation of endophilin A2 inhibits endocytosis of MT1-MMP and promotes ECM degradation. , 2005, Developmental cell.

[32]  M. Bäckdahl,et al.  Gelatinase A, Membrane Type 1 Matrix Metalloproteinase, and Extracellular Matrix Metalloproteinase Inducer mRNA Expression: Correlation with Invasive Growth of Breast Cancer , 2000, World Journal of Surgery.

[33]  A. Strongin,et al.  Mutation Analysis of Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) , 2001, The Journal of Biological Chemistry.

[34]  Jiahua Xu,et al.  Rac1 Mediates Type I Collagen-dependent MMP-2 Activation , 2001, The Journal of Biological Chemistry.

[35]  M. Stack,et al.  Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Schlessinger,et al.  Regulation of signal transduction and signal diversity by receptor oligomerization. , 1994, Trends in biochemical sciences.

[37]  J. Keski‐Oja,et al.  Oligomerization through Hemopexin and Cytoplasmic Domains Regulates the Activity and Turnover of Membrane-type 1 Matrix Metalloproteinase* , 2002, The Journal of Biological Chemistry.

[38]  A. Strongin,et al.  Matrix-dependent Proteolysis of Surface Transglutaminase by Membrane-type Metalloproteinase Regulates Cancer Cell Adhesion and Locomotion* , 2001, The Journal of Biological Chemistry.

[39]  Hiroshi Sato,et al.  Homophilic complex formation of MT1‐MMP facilitates proMMP‐2 activation on the cell surface and promotes tumor cell invasion , 2001, The EMBO journal.

[40]  M. Stack,et al.  Collagen Binding Properties of the Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) Hemopexin C Domain , 2002, The Journal of Biological Chemistry.

[41]  María Yáñez-Mó,et al.  ECM regulates MT1-MMP localization with β1 or αvβ3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells , 2002, The Journal of cell biology.

[42]  C. Gilles,et al.  Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[43]  A. Dautry‐Varsat,et al.  Inhibition of clathrin-coated pit assembly by an Eps15 mutant. , 1999, Journal of cell science.

[44]  Stephen J. Weiss,et al.  Regulation of Cell Invasion and Morphogenesis in a Three-Dimensional Type I Collagen Matrix by Membrane-Type Matrix Metalloproteinases 1, 2, and 3 , 2000, The Journal of cell biology.

[45]  Jean-Michel,et al.  SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. , 1998, Cancer research.

[46]  Hiroshi Sato,et al.  The C-terminal Region of Membrane Type Matrix Metalloproteinase Is a Functional Transmembrane Domain Required for Pro-gelatinase A Activation (*) , 1995, The Journal of Biological Chemistry.

[47]  D. Gingras,et al.  Rapid activation of matrix metalloproteinase-2 by glioma cells occurs through a posttranslational MT1-MMP-dependent mechanism. , 2000, Biochimica et biophysica acta.

[48]  Y. Okada,et al.  TIMP-2 Promotes Activation of Progelatinase A by Membrane-type 1 Matrix Metalloproteinase Immobilized on Agarose Beads* , 1998, The Journal of Biological Chemistry.

[49]  J. Burthem,et al.  Molecular pathogenesis of chronic myeloid leukaemia , 2003, Expert Reviews in Molecular Medicine.

[50]  J. Ward,et al.  MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover , 1999, Cell.

[51]  Stephen J. Weiss,et al.  Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[52]  C. Jackson,et al.  Three-dimensional collagen matrices induce delayed but sustained activation of gelatinase A in human endothelial cells via MT1-MMP. , 2000, The international journal of biochemistry & cell biology.

[53]  A. Strongin,et al.  Processing of Integrin αv Subunit by Membrane Type 1 Matrix Metalloproteinase Stimulates Migration of Breast Carcinoma Cells on Vitronectin and Enhances Tyrosine Phosphorylation of Focal Adhesion Kinase* , 2002, The Journal of Biological Chemistry.

[54]  Hiroshi Sato,et al.  Tetraspanin CD63 promotes targeting and lysosomal proteolysis of membrane-type 1 matrix metalloproteinase. , 2003, Biochemical and biophysical research communications.

[55]  M. McNiven,et al.  Disruption of Golgi structure and function in mammalian cells expressing a mutant dynamin. , 2000, Journal of cell science.